Validation of an inhouse developed therapeutic dosimetric software tool for the treatment of 177 LutetiumDOTATATE peptide receptor redionuclide therapy
dc.article.end-page | 289 | en |
dc.article.start-page | 277 | en |
dc.citation.doi | 10.1007/S12553-024-00818-X | en |
dc.contributor.author | B Van Wyk | en |
dc.contributor.author | F Hasford | en |
dc.contributor.author | N NYAKALE | en |
dc.contributor.author | Mboyo-Di-Tamba Vangu | en |
dc.date.accessioned | 2024-11-26T13:09:21Z | |
dc.date.available | 2024-11-26T13:09:21Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | SCOPUS | en |
dc.identifier.issn | 21907188 | en |
dc.identifier.uri | https://hdl.handle.net/10539/42914 | |
dc.journal.title | Validation of an inhouse developed therapeutic dosimetric software tool for the treatment of 177 LutetiumDOTATATE peptide receptor redionuclide therapy | en |
dc.journal.volume | 14 | en |
dc.title | Validation of an inhouse developed therapeutic dosimetric software tool for the treatment of 177 LutetiumDOTATATE peptide receptor redionuclide therapy | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 2.04 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client